Yellore Vivek S, Khan M Ali, Bourla Nirit, Rayner Sylvia A, Chen Michael C, Sonmez Baris, Momi Rominder S, Sampat Kapil M, Gorin Michael B, Aldave Anthony J
The Jules Stein Eye Institute, David Geffen School of Medicine at the University of California, Los Angeles, CA 90095, USA.
Mol Vis. 2007 Sep 24;13:1777-82.
To identify the genetic basis of Schnyder crystalline corneal dystrophy (SCCD) through screening positional candidate genes and UBIAD1, in which mutations have been associated with SCCD, in affected families.
The coding region of each of the 16 positional candidate genes for which mutation screening has not been previously reported was screened with polymerase chain reaction (PCR) amplification and automated sequencing in four affected individuals from two families with SCCD. In addition, the coding region of UBIAD1, located just outside of the originally described SCCD candidate interval on chromosome 1p36, was directly sequenced in affected and unaffected individuals from three families with SCCD.
Eighteen novel and 15 previously reported sequence variants were identified in 10 of the 16 positional candidate genes. Only two of the sequence variants segregated with the affected phenotype in either of the families screened. Both were novel single nucleotide polymorphisms (SNPs) predicted to result in synonymous amino acid substitutions in different predicted genes. However, one of these SNPs was also identified in control individuals, and the other SNP was not predicted to alter splicing. Screening of UBIAD1 revealed a different missense mutation in each of the three unrelated probands that was screened: p.Asn102Ser, p.Arg119Gly, and p.Leu121Val. Screening of the affected and unaffected relatives of the probands in whom the p.Asn102Ser and p.Leu121Val mutations were identified demonstrated that each mutation segregated with the affected phenotype. None of the three missense mutations was identified in 110 control individuals.
No presumed pathogenic coding region mutations were identified in the genes mapped to the candidate region for SCCD. However, missense mutations in UBIAD1, located just outside of the originally described SCCD fine mapped region, were identified in each of the three families with SCCD, confirming that mutations in UBIAD1 are associated with SCCD.
通过对定位候选基因以及已发现与施奈德结晶性角膜营养不良(SCCD)相关突变的泛醌生物合成蛋白1(UBIAD1)进行筛选,确定受累家系中SCCD的遗传基础。
利用聚合酶链反应(PCR)扩增和自动测序技术,对两个患有SCCD的家系中的4名受累个体,筛查16个此前未报道过突变筛查情况的定位候选基因的编码区。此外,对位于1号染色体1p36上最初描述的SCCD候选区间之外的UBIAD1编码区,在三个患有SCCD的家系的受累个体和未受累个体中进行直接测序。
在16个定位候选基因中的10个基因中,鉴定出18个新的和15个先前报道过的序列变异。在筛查的任何一个家系中,只有两个序列变异与受累表型共分离。两者均为新的单核苷酸多态性(SNP),预计会导致不同预测基因中的同义氨基酸替换。然而,其中一个SNP也在对照个体中被鉴定出,另一个SNP预计不会改变剪接。对UBIAD1的筛查显示,在筛查的三名无关先证者中各发现了一个不同的错义突变:p.Asn102Ser、p.Arg119Gly和p.Leu121Val。对鉴定出p.Asn102Ser和p.Leu121Val突变的先证者的受累和未受累亲属进行筛查,结果表明每个突变都与受累表型共分离。在110名对照个体中未鉴定出这三个错义突变中的任何一个。
在定位到SCCD候选区域的基因中,未鉴定出推测的致病编码区突变。然而,在三个患有SCCD的家系中的每一个家系中,均在最初描述的SCCD精细定位区域之外的UBIAD1中鉴定出错义突变,证实UBIAD1中的突变与SCCD相关。